Geode Capital Management LLC increased its position in Henry Schein, Inc. (NASDAQ:HSIC) by 1.9% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,602,922 shares of the company’s stock after purchasing an additional 47,496 shares during the period. Geode Capital Management LLC owned 1.86% of Henry Schein worth $192,603,000 at the end of the most recent reporting period.
A number of other large investors have also recently bought and sold shares of the stock. Globeflex Capital L P lifted its holdings in Henry Schein by 6.3% in the first quarter. Globeflex Capital L P now owns 2,212 shares of the company’s stock worth $153,000 after acquiring an additional 131 shares during the last quarter. HighTower Advisors LLC lifted its holdings in Henry Schein by 2.2% in the second quarter. HighTower Advisors LLC now owns 5,976 shares of the company’s stock worth $441,000 after acquiring an additional 131 shares during the last quarter. Bessemer Group Inc. lifted its holdings in Henry Schein by 1.6% in the first quarter. Bessemer Group Inc. now owns 9,860 shares of the company’s stock worth $683,000 after acquiring an additional 151 shares during the last quarter. Stephens Inc. AR lifted its holdings in Henry Schein by 8.2% in the second quarter. Stephens Inc. AR now owns 2,171 shares of the company’s stock worth $161,000 after acquiring an additional 164 shares during the last quarter. Finally, Cambridge Investment Research Advisors Inc. lifted its holdings in Henry Schein by 4.3% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 4,566 shares of the company’s stock worth $316,000 after acquiring an additional 187 shares during the last quarter. Institutional investors and hedge funds own 93.16% of the company’s stock.
HSIC opened at $77.72 on Thursday. The business’s 50 day moving average is $77.20 and its 200-day moving average is $76.15. The stock has a market cap of $10.86 billion, a PE ratio of 18.29, a price-to-earnings-growth ratio of 1.32 and a beta of 0.88. The company has a current ratio of 1.79, a quick ratio of 0.98 and a debt-to-equity ratio of 0.18. Henry Schein, Inc. has a twelve month low of $59.44 and a twelve month high of $83.45.
A number of equities analysts have issued reports on HSIC shares. Barrington Research raised their target price on shares of Henry Schein from $91.00 to $95.00 and gave the stock an “outperform” rating in a report on Wednesday, August 4th. Zacks Investment Research cut shares of Henry Schein from a “buy” rating to a “hold” rating and set a $82.00 target price on the stock. in a report on Tuesday, October 5th. Finally, Piper Sandler lifted their price target on Henry Schein from $89.00 to $95.00 and gave the company an “overweight” rating in a report on Tuesday, August 3rd. One analyst has rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of $90.50.
Henry Schein Profile
Henry Schein, Inc engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Featured Article: Why are percentage gainers important?
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.